Harsch Mutya Insider Trades

Insider Trading History

Track insider trading activity for Harsch Mutya. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $81.1k 121,898 shares
Last Trade
Mar 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.4k 4,007 shares
$0.60
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $83.7k 125,905 shares
Last Trade
Dec 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.08k 3,579 shares
$0.58
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $86.1k 129,484 shares
Last Trade
Sep 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.22k 3,581 shares
$0.34
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $88.5k 133,065 shares
Last Trade
Jun 30, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$5.91k 3,581 shares
$1.65
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $90.9k 136,646 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06k 1,145 shares
$0.93
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $90.1k 135,501 shares
Last Trade
Mar 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.9k 8,828 shares
$1.58
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $153k 230,000 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$637k 230,000 shares
$2.77
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $96k 144,329 shares
Last Trade
Dec 31, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.7k 4,697 shares
$3.35
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $99.1k 149,026 shares
Last Trade
Sep 30, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$197 105 shares
$1.88
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $99.2k 149,131 shares
Last Trade
Jul 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$275 143 shares
$1.92
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
CHIEF LEGAL OFFICER AND GC
Holding Value $99.3k 149,274 shares
Last Trade
Apr 01, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$496 161 shares
$3.08
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $99.4k 149,435 shares
Last Trade
Jan 02, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$367 161 shares
$2.28
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $99.5k 149,596 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$291k 125,000 shares
$2.33
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $57.9k 87,096 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$338k 125,000 shares
$2.70
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $16.4k 24,596 shares
Last Trade
Oct 02, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.42k 1,154 shares
$3.83
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $17.1k 25,750 shares
Last Trade
Jun 30, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$644 157 shares
$4.10
$0.67
Satsuma Pharmaceuticals
Satsuma Pharmaceuticals STSA
Director
Holding Value $0 0 shares
Last Trade
Jun 08, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$77k 70,000 shares
$1.10
$1.10
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $17.2k 25,907 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23k 3,664 shares
$6.29
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $14.8k 22,243 shares
Last Trade
Mar 31, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.47k 478 shares
$3.08
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Chief Legal Officer And GC
Holding Value $15.1k 22,721 shares
Last Trade
Mar 20, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25k 10,000 shares
$2.50
$0.67

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up